Park Ha Biological Technology Co., Ltd.
Case Overview
61 Days Left to Seek Lead Plaintiff
| Lead Plaintiff Deadline: | Lead Plaintiff Deadline: 09/28/2026 |
| Status: | Status: Investigating |
| Company Name: | Company Name: Park Ha Biological Technology Co., Ltd. |
| Court: | Court: Southern District of New York |
| Case Number: | Case Number: 1:26cv06421 |
| Class Period: | Class Period: 12/24/2024 - 07/08/2025 |
| Ticker: | Ticker: BYAH |
| Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
| Related Practices: | Related Practices: Securities |
On December 27, 2024, PHH filed its IPO Prospectus, permitting the Company to issue 1,200,000 ordinary shares at an initial offering price of $4.00 per share (the “Prospectus”). The Prospectus formed part of the registration statement filed in connection with PHH’s IPO (the “Registration Statement”). PHH conducted closed its IPO on December 30, 2024. The total outstanding shares after the IPO were disclosed to be 26,200,000 ordinary shares. Therefore, the IPO represented less than 5% of total PHH ownership.
The lawsuit alleges that the Registration Statement was materially false and misleading and/or failed to disclose that: (i) PHH was the subject of a market manipulation and fraudulent promotion scheme involving social media-based misinformation and impersonators posing as financial professionals and (ii) PHH’s IPO was intentionally structured with an extremely low public float to enable the manipulation scheme This allegedly led to a significant increase in PHH’s stock price in the six months following the Company’s IPO, with the stock price increasing from $4.00 in December 2024 to close at $41.01 on July 7, 2025.
On July 8, 2025, however, PHH’s stock price declined by approximately 93% to close at $2.99 per share.